Mutual fund holdings in Aristo Bio-Tech And Lifescience Limited: who holds it and who bought and sold in Sep 2026, with its other institutional holdings, each beside the price.
₹90.00▲ +4.7%
NSE close, 4 Nov 2026 · 1-year range ₹56.05 – ₹158.00
Data as of10 sources, each card shows its own date
MF: Sep 2026 portfolios (monthly), 45 fund houses coveredShares outstanding: NSE equity list, 4 Nov 2026Delivery: NSE security-wise delivery, 4 Nov 2026 · 155 days collectedDeals: NSE deal files, 4 Nov 2026SLBM: NSE, 4 Nov 2026 · 56 days collectedMTF: NSE, 3 Nov 2026 · 55 days collectedFlags: NSE, 4 Nov 2026FPI: no shareholding pattern collected yetPledge: no shareholding pattern collected yetInsider: Trades dated 7 Aug 2026 to 4 Nov 2026 (disclosures collected since 3 May 2026)
MF holding, % of equity
None held
Sep 2026
FPI holding, % of equity
—
No shareholding pattern for Aristo Bio-Tech And Lifescience has been collected yet.
Fund houses holding
0
0 entered, 0 exited · Sep 2026
Promoter pledge
—
No shareholding pattern for Aristo Bio-Tech And Lifescience has been collected yet.
Delivery
96.5%▼ −3.3 pp
4 Nov 2026
MTF book
—
NSE listed no margin trading position for Aristo Bio-Tech And Lifescience on any of the 55 days collected, 14 Aug 2026 to 3 Nov 2026.
Mutual funds
i
What it is. Shares of this company held by mutual funds, taken from the portfolio each fund house publishes for every month end. Some index-only schemes publish only every quarter. "Houses" counts the fund houses holding it in an active scheme.
How to read it. "% of equity" is the shares funds hold divided by all the company's shares. A change between two months compares only the houses with a portfolio in both months. Share counts move when funds add to or cut a holding, or when a split or bonus is applied.
Does not show: Trades inside the month, or why a fund changed its holding.
AMC portfolios, Sep 2026 · 45 fund houses covered
No tracked fund house held ARISTO in Sep 2026.
Price
NSE close by day · 31 Jan 2023 to 4 Nov 2026
₹90.00 NSE close, 4 Nov 2026
31 Jan 20234 Nov 2026
₹56.05 to ₹158.00, split or bonus adjusted. Since first held = the close at the end of the first month any tracked fund held it, to the latest close.
Delivery
Delivery
i
What it is. Of all shares traded in a day, the part that was settled by delivery: the buyer receives the shares in their demat account. NSE counts this per client, so the rest is shares a client bought and sold within the same day (intraday).
How to read it. NSE publishes the share for every stock every day. Stocks differ in how much they are traded within the day, so compare a stock with its own past rather than with another stock. A 5-day figure smooths out single-day noise.
Does not show: Who the buyers were, or whether they plan to keep the shares.
4 Nov 2026
Share of the day's traded volume taken into demat instead of squared off the same day. A higher share means more of the trading was buying to hold.
96.5%▼ −3.3 pp vs 20-day average
20-day average 99.8% · 15th percentile of 155 days collected
2 Sep 20264 Nov 2026
By month over 46 months (Jan 2023 to Oct 2026), 81.3% of shares traded were delivered; lowest month 62.1% (Apr 2023), highest 100.0% (Dec 2024).
Share of each session's traded shares taken into demat. High delivery on a falling price means holders took the shares, not just day traders.
100%100%85%71%
Nov 2025Jan 2026Mar 2026May 2026Jul 2026Sep 2026
Delivery
F&O and margin
Red flags
i
What it is. Exchange lists that restrict trading in a stock: the F&O ban (no fresh F&O positions), and the Additional and Graded Surveillance Measures (ASM and GSM), which tighten trading conditions with steps such as higher margins, narrower price bands and trade-for-trade settlement.
How to read it. The card shows whether the stock is on a list today, from the exchange's daily files.
Does not show: Anything about the company beyond being listed.
4 Nov 2026
The exchange's own lists: F&O ban and surveillance. They say the stock is on a list, not why it moved.
No F&O
Aristo Bio-Tech And Lifescience has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed Aristo Bio-Tech And Lifescience under no ASM or GSM stage on 4 Nov 2026. Pledge invocations are not available yet.
NSE, 4 Nov 2026
Nothing to show for Aristo Bio-Tech And Lifescience in the period checkedNamed FPIs at 1% or more: No shareholding pattern for Aristo Bio-Tech And Lifescience has been collected yet. · Promoter pledge: No shareholding pattern for Aristo Bio-Tech And Lifescience has been collected yet. · Bulk and block deals: No bulk or block deals in Aristo Bio-Tech And Lifescience from 7 Aug 2026 to 4 Nov 2026. · Insider and promoter: No insider or promoter trade in Aristo Bio-Tech And Lifescience dated 7 Aug 2026 to 4 Nov 2026 was disclosed. · MTF book: NSE listed no margin trading position for Aristo Bio-Tech And Lifescience on any of the 55 days collected, 14 Aug 2026 to 3 Nov 2026. · SLBM borrowing: NSE listed no securities-lending (SLB) open position for Aristo Bio-Tech And Lifescience on any of the 56 days collected, 14 Aug 2026 to 4 Nov 2026. No SLBM trades in Aristo Bio-Tech And Lifescience on 4 Nov 2026.
On NSE ↗
NSE's own public pages for ARISTO; this site does not copy them
